What Researchers Did
The researchers randomly assigned 19 people who had radiotherapy for cancers of the throat and nasopharynx to receive hyperbaric oxygen therapy (HBOT) afterward or not, then compared their quality of life and side effects.
What They Found
In this small randomized trial of 19 patients with oropharyngeal and nasopharyngeal cancer, patients who received HBOT after radiotherapy reported better quality of life scores than those who did not, with significant differences in swallowing, dry mouth, sticky saliva, eating in public and mouth pain. HBOT was 30 sessions at 2.5 ATA, with 90 minutes of oxygen breathing daily, 5 days per week, started shortly after radiotherapy ended. The reported p-values were 0.011 for swallowing, 0.009 for dry mouth, 0.01 for sticky saliva, 0.027 for eating in public, and p less than 0.0001 for mouth pain. The abstract reports that better scores were obtained with HBOT on all quality of life items.
What This Means for Canadian Patients
For people facing radiotherapy for throat or nasopharyngeal cancer, this trial reports that those who got HBOT right after radiotherapy rated their swallowing, saliva and mouth pain better than those who did not. These are early results from a small group, so they show an association in this trial and do not tell us how any one person would respond. Anyone considering HBOT should talk with their cancer care team.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
Only 19 patients were randomized, and the abstract describes these as early results, so the findings are limited by the small sample and may change with more patients and longer follow-up.